Barry Canton is 10% Owner at Ginkgo Bioworks Holdings, Inc. (DNA). They have made 49 open-market trades across 1 company since 2022, most recently 2026-04-10.
CIK 0001882756
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 49 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNA | 436,422 | $4.5M |
Shares reported on the most recent Form 4, priced at the 2026-04-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 78% | 90% |
| Avg Move | -3.3% | -11.7% | -21.9% |
| Scored | 49 | 49 | 49 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNA | SELL | 2026-04-10 | 2026-04-13 | $6.43 | $802K | +12.9% | +26.2% | +32.8% |
| DNA | SELL | 2026-04-08 | 2026-04-10 | $6.66 | $175K | +34.0% | +37.6% | +54.6% |
| DNA | SELL · 10b5-1 | 2023-12-20 | 2023-12-22 | $1.77 | $133K | -13.1% | -30.1% | -35.2% |
| DNA | SELL · 10b5-1 | 2023-12-13 | 2023-12-15 | $1.53 | $173K | +9.9% | -24.2% | -34.2% |
| DNA | SELL · 10b5-1 | 2023-12-06 | 2023-12-08 | $1.32 | $99K | +25.9% | +15.6% | -11.1% |
| DNA | SELL · 10b5-1 | 2023-11-29 | 2023-12-01 | $1.40 | $211K | +4.3% | +21.0% | +10.1% |
| DNA | SELL · 10b5-1 | 2023-11-22 | 2023-11-27 | $1.41 | $106K | -2.9% | +29.2% | +2.2% |
| DNA | SELL · 10b5-1 | 2023-11-15 | 2023-11-17 | $1.48 | $167K | -14.6% | +4.6% | +2.6% |
| DNA | SELL · 10b5-1 | 2023-11-08 | 2023-11-13 | $1.40 | $105K | +8.1% | +6.7% | +11.9% |
| DNA | SELL · 10b5-1 | 2023-11-01 | 2023-11-03 | $1.43 | $108K | -6.0% | -15.7% | -23.5% |
| DNA | SELL · 10b5-1 | 2023-10-25 | 2023-10-27 | $1.47 | $111K | +8.8% | +1.5% | -8.0% |
| DNA | SELL · 10b5-1 | 2023-10-18 | 2023-10-20 | $1.65 | $248K | -11.7% | -0.6% | -23.4% |
| DNA | SELL · 10b5-1 | 2023-10-11 | 2023-10-13 | $1.71 | $129K | -11.1% | -21.0% | -17.3% |
| DNA | SELL · 10b5-1 | 2023-10-04 | 2023-10-06 | $1.65 | $248K | -1.2% | -9.0% | -6.6% |
| DNA | SELL · 10b5-1 | 2023-09-27 | 2023-09-29 | $1.79 | $270K | -2.8% | -26.1% | -1.7% |
| DNA | SELL · 10b5-1 | 2023-09-20 | 2023-09-22 | $1.79 | $203K | -7.3% | -15.8% | -0.6% |
| DNA | SELL · 10b5-1 | 2023-09-13 | 2023-09-15 | $2.02 | $152K | -7.3% | -12.5% | -16.1% |
| DNA | SELL · 10b5-1 | 2023-09-06 | 2023-09-08 | $2.18 | $328K | -12.4% | -16.7% | -36.4% |
| DNA | SELL · 10b5-1 | 2023-08-30 | 2023-09-01 | $2.25 | $340K | -11.9% | -23.1% | -42.0% |
| DNA | SELL · 10b5-1 | 2023-08-23 | 2023-08-25 | $1.72 | $130K | +19.2% | -2.3% | -17.5% |
| DNA | SELL · 10b5-1 | 2023-08-16 | 2023-08-18 | $1.65 | $187K | +37.2% | +12.8% | -11.0% |
| DNA | SELL · 10b5-1 | 2023-08-09 | 2023-08-11 | $1.86 | $210K | -3.2% | +13.0% | -31.9% |
| DNA | SELL · 10b5-1 | 2023-08-02 | 2023-08-04 | $2.06 | $233K | -24.5% | +4.2% | -28.7% |
| DNA | SELL · 10b5-1 | 2023-07-26 | 2023-07-28 | $2.36 | $267K | -18.0% | -26.9% | -40.4% |
| DNA | SELL · 10b5-1 | 2023-07-19 | 2023-07-21 | $2.38 | $358K | -15.0% | -30.8% | -35.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.